Iovance Biotherapeutics Inc (NASDAQ:IOVA)
| 9.59 Delayed Data As of Sep 30 |  +0.05 / +0.52%Today’s Change | 6.18 Today|||52-Week Range 27.96 | -49.76% Year-to-Date |
Latest IOVA News | Press Releases
No recent news for Iovance Biotherapeutics Inc.
Today’s Trading
| Previous close | 9.53 |
| Today’s open | 9.46 |
| Day’s range | 9.46 - 10.09 |
| Volume | 1,757,122 |
| Average volume (3 months) | 4,246,557 |
| Market cap | $1.5B |
Data as of 4:01pm ET, 09/30/2022
Growth & Valuation
| Earnings growth (last year) | -18.87% |
| Earnings growth (this year) | -12.68% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 2.42 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| XNCRXencor Inc | +0.46 | +1.80% |
| ALLOAllogene Therapeutic... | +0.48 | +4.65% |
| TVTXTravere Therapeutics... | 0.00 | 0.00% |
| TLRYTilray Brands Inc | -0.11 | -3.85% |
Data as of 4:02pm ET, 09/30/2022
Financials
| Next reporting date | November 9, 2022 |
| EPS forecast (this quarter) | -$0.64 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$342.3M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters San Carlos, California |
Forecasts
